Back to Trials
NCT07351656NARecruiting

A Study Of Heart Disease Using AI-Enabled Electrocardiography And Focused Cardiac Ultrasound

Mayo Clinic

Start Date

3/9/2026

Completion Date

2/1/2028

Summary

A study to evaluate feasibility, diagnostic yield, accuracy, and actionable thresholds of POC, immediate-feedback AI-ECG + AI FoCUS screening for cardiac disease in well described community populations.

Eligibility Criteria

Age Range: 15 years to No maximum

Adolescents and young adults: Inclusion Criteria: * Enrollment in a high-school, college or a resident in MN during the study period * Age 15-29 years * Informed consent (and assent for minors) Exclusion Criteria: * Presence of a pacemaker or defibrillator * Inability to obtain a quality ECG tracing Community dwelling adults: Inclusion Criteria: • Adult patients (\>30 years of age, with pre-specified subgroups 30-64 and 65+)) Exclusion Criteria: • Inability to provide informed consent to participate in the study Pregnant women: Inclusion Criteria: * Adult female aged 18 to 49 years * Pregnant at the time of enrollment * Receiving obstetric care at identified study site(s) * Willing and able to provide informed consent Exclusion Criteria: • Inability to provide consent

Interventions

DIAGNOSTIC_TEST

Focused Cardiac Ultrasound

DIAGNOSTIC_TEST

6-Lead AI-ECG

DIAGNOSTIC_TEST

12-Lead AI-ECG

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Heart Disease

Locations

Mayo Clinic in Rochester

Rochester, Minnesota 55905

United States